CrossrefScheda informativa
Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-11-03
DOI: 10.1111/apt.71077 ↗Abstract
Abstract non disponibile.
EUVIMED